Medicare Enrolled

Dr. Brandon McNally, M.D.

Dermatopathology Physician · Grandville, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3434 RIVERTOWN POINT CT SW, Grandville, MI 49418
6162573344
In practice since 2009 (17 years)
NPI: 1073740833 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McNally from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McNally? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McNally

Dr. Brandon McNally is a dermatopathology physician in Grandville, MI, with 17 years of NPI registration. Based on federal Medicare data, Dr. McNally performed 2,581 Medicare services across 1,551 unique beneficiaries.

Between the years covered by Open Payments, Dr. McNally received a total of $5,754 from 33 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McNally is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 50% volume in MI $5,754 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,581
Medicare services
Top 50% in MI for dermatopathology physician
1,551
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~152 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
1,414 $50 $118
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
264 $5 $10
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
191 $64 $148
Special tissue stain, multiplex
A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide.
116 $125 $269
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
109 $34 $76
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
97 $58 $98
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
92 $33 $121
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
72 $79 $167
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
63 $53 $143
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $35 $59
Special stain test for organisms
A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results.
34 $65 $137
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
23 $37 $77
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
20 $41 $100
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $52 $145
Pathology tissue examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis.
17 $26 $72
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,754
Total received (2020-2024)
Avg $1,151/year across 5 years
Top 14% in MI for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,621 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$133 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,253
2023
$2,360
2022
$612
2021
$366
2020
$164

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$388
GENZYME CORPORATION
$268
Dermavant Sciences, Inc.
$214
ABBVIE INC.
$212
Janssen Biotech, Inc.
$201
PFIZER INC.
$178
Boehringer Ingelheim Pharmaceuticals, Inc.
$112
Arcutis Biotherapeutics, Inc.
$86
E.R. Squibb & Sons, L.L.C.
$85
Amgen Inc.
$84
SUN PHARMACEUTICAL INDUSTRIES INC.
$71
UCB, Inc.
$71
Regeneron Healthcare Solutions, Inc.
$64
Organon Llc
$51
Incyte Corporation
$50
Fresenius Kabi USA, LLC
$46
Lilly USA, LLC
$21
Biocon Biologics Inc
$17
Organogenesis Inc.
$17
Ortho Dermatologics, a division of Bausch Health US, LLC
$17
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2020-2024) ›
Novartis Pharmaceuticals Corporation
$846
Janssen Biotech, Inc.
$786
ABBVIE INC.
$644
GENZYME CORPORATION
$454
Dermavant Sciences, Inc.
$442
Regeneron Healthcare Solutions, Inc.
$307
PFIZER INC.
$297
Boehringer Ingelheim Pharmaceuticals, Inc.
$260
Amgen Inc.
$255
E.R. Squibb & Sons, L.L.C.
$213
Lilly USA, LLC
$134
AbbVie Inc.
$127
UCB, Inc.
$125
Arcutis Biotherapeutics, Inc.
$119
Incyte Corporation
$87
SUN PHARMACEUTICAL INDUSTRIES INC.
$71
Fresenius Kabi USA, LLC
$65
Biofrontera Inc.
$59
Ortho Dermatologics, a division of Bausch Health US, LLC
$55
Almirall LLC
$53
Organon Llc
$51
Organon LLC
$50
Kyowa Kirin, Inc.
$39
Genentech USA, Inc.
$34
Sun Pharmaceutical Industries Inc.
$34
Blueprint Medicines Corporation
$28
VYNE Pharmaceuticals Inc.
$25
Mylan Institutional Inc.
$20
SANOFI-AVENTIS U.S. LLC
$19
Biocon Biologics Inc
$17
Organogenesis Inc.
$17
LEO Pharma Inc.
$14
MAYNE PHARMA COMMERCIAL LLC
$8
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
ADBRY · AMELUZ · AMZEEQ · Bimzelx · CIBINQO · COSENTYX · CYLTEZO · Cimzia · DUPIXENT · EUCRISA · Enbrel · HADLIMA · HUMIRA · Hulio · IDACIO · ILUMYA · Klisyri · LEVULAN KERASTICK · LIBTAYO · OPZELURA · Otezla · Poteligeo · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Seysara · Sotyktu · TALTZ · TREMFYA · VTAMA · XELJANZ · Xolair · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatopathology physician in Grandville?
Compare dermatopathology physicians in the Grandville area by procedure volume, costs, and industry payment transparency.
Browse dermatopathology physicians nearby

Geographic Context

Dermatopathology physicians within 10 mi
4
Per 100K population
0.6
County median income
$80,390
Nearest hospital
UNIVERSITY OF MICHIGAN HEALTH - WEST
2.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McNally is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of MI peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McNally experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. McNally performed 1,414 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McNally receive payments from pharmaceutical companies?
Yes. Dr. McNally received a total of $5,754 from 33 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McNally's costs compare to other dermatopathology physicians in Grandville?
Dr. McNally's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McNally) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →